company
Amgen, Inc.
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-07-01Amgen, Inc. — Class II recall: Sensipar (cinacalcet) Tablets, 30mg, 30-count bottles, Rx Only, Distributed by:…
- fda_recall · drug_recall2026-07-01Amgen, Inc. — Class II recall: Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 5551…
- fda_recall · drug_recall2026-07-01Amgen, Inc. — Class II recall: Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by:…
- fda_recall · drug_recall2026-07-01Amgen, Inc. — Class II recall: Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by:…
- fda_recall · drug_recall2026-07-01Amgen, Inc. — Class II recall: Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Tho…
Frequently asked questions
- How many FDA warning letters has Amgen, Inc. received?
- Argus HQ has not recorded an FDA warning letter for Amgen, Inc. in our current dataset.
- What FDA recalls has Amgen, Inc. issued?
- Argus HQ has recorded 5 FDA recalls tied to Amgen, Inc..
- Is Amgen, Inc. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 5 recalls, and 0 approval records for Amgen, Inc.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.